Your Article Summary
See Latest ArticlesCochrane Musculoskeletal Group review: Acute gout
The Journal of Family Practice, 07/02/09
Winzenberg T et al. - Gout afflicts about 2% of men over age 30 and women over age 50 and its prevalence appears to be increasing. Options for treating acute gout include nonsteroidal anti-inflammatory drugs (NSAIDs), colchicine, and intra-articular and systemic corticosteroids. Choosing among them can be challenging, however, because the evidence that one or another of these options yields real benefit is of varying strength. Using NSAIDs can be problematic with increasing age, as comorbidities like gastrointestinal (GI) bleeding, renal failure, heart failure, and cardiovascular risk increase and anticoagulant therapy is more likely to be in use. That’s where the kind of systematic reviews Cochrane Musculoskeletal Group (CMSG) performs can be of real help.
- Test your skills with 2 cases
- All 22 participants who took colchicine developed diarrhea or vomiting within 24 hours of initiating therapy
- One RCT found that oral prednisolone 35 mg daily and naproxen 500 mg twice daily were clinically equivalent
- NSAIDs are a reasonable first option, provided there are no contraindications
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
New Anticoagulants in Atrial Fibrillation
Seminars in Thrombosis and Hemostasis, 10/02/09
A Randomized, Double-Blind Study Examining the Comparative Efficacies and Safety of Inhaled Epinephrine and Nasal Decongestant in Hospitalized Infants With Acute Bronchiolitis
The Pediatric Infectious Disease Journal, 11/17/09
Today in Orthopedics/Sports Med...keeping you current
Receive free subspecialty "5-minute updates" via email
Acute back pain: benefits and risks of current treatments
Current Medical Research and Opinion, 11/19/09
Achilles Tendon Rupture in Athletes
Journal of Surgical Orthopaedic Advances, 11/02/09
Heat injury in youth sport
British Journal of Sports Medicine, 11/16/09
Today in Pain Management...keeping you current
Receive free subspecialty "5-minute updates" via email
Escitalopram and Venlafaxine for the Prophylaxis of Migraine Headache Without Mood Disorders
Clinical Neuropharmacology, 10/02/09
Acute back pain: benefits and risks of current treatments
Current Medical Research and Opinion, 11/19/09
Prevention of episodic migraines with topiramate: results from a non-interventional study in a general practice setting
The Journal of Headache and Pain, 11/10/09